Art. 4 Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…

Conditions for approval

In forcecited 72×
1.

An active substance shall be approved for an initial period not exceeding 10 years if at least one biocidal product containing that active substance may be expected to meet the criteria laid down in point (b) of Article 19(1) taking into account the factors set out in Article 19(2) and (5). An active substance that falls under Article 5 may only be approved for an initial period not exceeding five years.

2.

The approval of an active substance shall be restricted to those product-types for which relevant data have been submitted in accordance with Article 6.

3.

The approval shall specify the following conditions, as appropriate:

(a)

the minimum degree of purity of the active substance;

(b)

the nature and maximum content of certain impurities;

(c)

the product-type;

(d)

manner and area of use including, where relevant, use in treated articles;

(e)

designation of categories of users;

(f)

where relevant, characterisation of the chemical identity with regard to stereoisomers;

(g)

other particular conditions based on the evaluation of the information related to that active substance;

(h)

the date of approval and the expiry date of the approval of the active substance.

4.

The approval of an active substance shall not cover nanomaterials except where explicitly mentioned.

The 10 that are cited most themselves, of 72.

  • Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme…6Law

    … компетентен орган оценява заявлението в съответствие с членове 4 и 5 от Регламент (ЕС) № 528/2012, включително, ако е приложимо, всяко …

  • Judgment of the General Court (Seventh Chamber) of 15 September 2021. Laboratoire Pareva and Biotech3D Ltd & Co. KG v European Commission.Decision

    It should be borne in mind that the approval procedure for active substances laid down in Chapter II of Regulation No 528/2012 is based on the submission of an application for approval. In that regard, under Article 6 of that regulation, …

    15 Sep 2021 · 62018TJ0337

  • Decision_act (EU) 2024/2402Law

    … все още отговаря на условията за одобряване, установени в член 4, параграф 1 от Регламент (ЕС) № 528/2012. Поради това в крайна сметка не …

  • Judgment of the General Court (Ninth Chamber) of 17 January 2024. Troy Chemical Company BV and Troy Corp. v European Commission.Decision

    Both Article 10(1) of Directive 98/8 and Article 4(1) of Regulation No 528/2012 merely set a maximum initial approval period for such substances, which may not exceed 10 years.

    17 Jan 2024 · 62021TJ0297

  • Judgment of the Court (First Chamber) of 14 October 2021. Biofa AG v Sikma D. Vertriebs GmbH und Co. KG.Decision

    In that regard, it must be borne in mind that the definition of ‘active substance’, under Article 3(1)(c) of that regulation, covers any substance or micro-organism which has an action on or against harmful organisms. Although, unlike …

    14 Oct 2021 · 62020CJ0029

  • Commission Implementing Regulation (EU) No 1036/2013 of 24 October 2013 approving etofen…Law

    … не следва да обхваща такива материали в съответствие с член 4, параграф 4 от Регламент (ЕС) № 528/2012.

  • Commission Implementing Regulation (EU) No 945/2013 of 2 October 2013 to approve cyperme…Law

    … не следва да обхваща такива материали в съответствие с член 4, параграф 4 от Регламент (ЕС) № 528/2012.

  • Judgment of the General Court (Seventh Chamber) of 16 November 2022 (Extracts). Sciessent LLC v European Commission.Decision

    16 Nov 2022 · 62020TJ0122

  • Decision_act (EU) 2019/1973Law

    … от продуктови типове 2 и 7, тъй като условията, предвидени в член 4, параграф 1 от Регламент (ЕС) № 528/2012, не са изпълнени.

  • Regulation (EU) 2015/416Law

    … не следва да обхваща такива материали, в съответствие с член 4, параграф 4 от Регламент (ЕС) № 528/2012.